Vor Biopharma Ownership | Who Owns Vor Biopharma?

Overview Forecast RevenueFinancials Chart

Vor Biopharma Ownership Summary

Vor Biopharma is owned by 69.87% institutional investors, 1.17% insiders, and 28.96% retail investors. Ra capital management is the largest institutional shareholder, holding 33.44% of VOR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.11% of its assets in Vor Biopharma shares.

VOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vor Biopharma	69.87%	1.17%	28.96%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	22.75M	33.44%	$22.75M
Fmr	7.08M	10.40%	$7.08M
5am venture management	6.36M	9.35%	$6.36M
Laurion capital management lp	2.53M	3.71%	$2.53M
Vanguard group	1.95M	2.87%	$1.95M
Johnson & johnson	1.07M	1.58%	$1.07M
Sarissa capital management lp	618.00K	0.91%	$618.00K
Blackrock	497.70K	0.73%	$497.70K
Renaissance	495.30K	0.73%	$495.30K
Mai capital management	470.07K	0.69%	$470.07K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
5am venture management	6.36M	1.42%	$6.36M
Ra capital management	22.75M	0.30%	$22.75M
Johnson & johnson	1.07M	0.27%	$1.07M
Sarissa capital management lp	618.00K	0.10%	$618.00K
Laurion capital management lp	2.53M	0.03%	$2.53M
Ground swell capital	20.67K	0.02%	$20.67K
Point72 asia (singapore) pte.	63.26K	0.01%	$63.26K
Mai capital management	470.07K	0.00%	$470.07K
Bridgeway capital management	165.90K	0.00%	$165.90K
Exchange traded concepts	117.79K	0.00%	$117.79K

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	375.34K	0.00%	282.17K
Millennium management	389.64K	0.00%	231.25K
Susquehanna group, llp	247.17K	-	220.59K
Jane street group	222.50K	0.00%	203.01K
Renaissance	495.30K	0.00%	160.64K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-6.46M
Blackrock	497.70K	-	-1.75M
Woodline partners lp	-	-	-1.11M
Artal group	-	-	-1.00M
Laurion capital management lp	2.53M	0.03%	-657.44K

New Positions

Holder	Shares	% Assets	Change	Value
Qube research	95.37K	0.00%	95.37K	$95.37K
Point72 asia (singapore) pte.	63.26K	0.01%	63.26K	$63.26K
Cubist systematic strategies	52.91K	0.00%	52.91K	$52.91K
Ground swell capital	20.67K	0.02%	20.67K	$20.67K
Sei investments	17.60K	-	17.60K	$17.60K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Nisa investment advisors	-45.00
Citadel advisors	-100.00
Smartleaf asset management	-102.00
Royal bank of canada	-870.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	55	-19.12%	47,833,717	-12.27%	69	1.09%	19	-51.28%	18	5.88%
Jun 30, 2024	68	-2.86%	54,521,316	-7.51%	80	1.04%	39	34.48%	17	-19.05%
Mar 31, 2024	70	14.75%	58,949,485	-1.10%	87	1.13%	29	7.41%	21	50.00%
Dec 31, 2023	61	-	59,603,001	-1.01%	88	1.09%	27	35.00%	14	-12.50%
Sep 30, 2023	61	-16.44%	60,212,882	-0.92%	89	1.07%	20	-45.95%	16	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	2.13M	3.11%	10.31K
Fidelity Growth Compy Commingled Pl O	2.12M	3.10%	-
Fidelity Growth Company Fund	1.44M	2.10%	-3.05K
Vanguard Total Stock Mkt Idx Inv	1.39M	2.02%	-
Fidelity VIP Growth Initial	618.39K	0.90%	-
Fidelity Select Biotechnology	614.60K	0.90%	-
Fidelity Capital Appreciation	610.40K	0.89%	-
Fidelity Growth Company K6	517.83K	0.76%	-8.94K
Vanguard Institutional Extnd Mkt Idx Tr	519.63K	0.76%	-
Fidelity Advisor Equity Growth I	474.17K	0.69%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 03, 2024	Attar Eyal C.	CHIEF MEDICAL OFFICER	Sell	$20.36K
Nov 16, 2021	5AM Ventures VI, L.P.	-	Sell	$1.41M
Nov 16, 2021	5AM Ventures VI, L.P.	-	Sell	$3.65M
Nov 16, 2021	PARMAR KUSH		Sell	$1.41M
Nov 16, 2021	PARMAR KUSH		Sell	$3.65M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	1
2024 Q1	-	-
2023 Q4	-	-

VOR Ownership FAQ

Who Owns Vor Biopharma?

Vor Biopharma shareholders are primarily institutional investors at 69.87%, followed by 1.17% insiders and 28.96% retail investors. The average institutional ownership in Vor Biopharma's industry, Biotech Stocks , is 47.04%, which Vor Biopharma exceeds.

Who owns the most shares of Vor Biopharma?

Vor Biopharma’s largest shareholders are Ra capital management (22.75M shares, 33.44%), Fmr (7.08M shares, 10.40%), and 5am venture management (6.36M shares, 9.35%). Together, they hold 53.19% of Vor Biopharma’s total shares outstanding.

Does Blackrock own Vor Biopharma?

Yes, BlackRock owns 0.73% of Vor Biopharma, totaling 497.7K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 497.7K$. In the last quarter, BlackRock decreased its holdings by -1.75M shares, a -77.86% change.

Who is Vor Biopharma’s biggest shareholder by percentage of total assets invested?

5am venture management is Vor Biopharma’s biggest shareholder by percentage of total assets invested, with 1.42% of its assets in 6.36M Vor Biopharma shares, valued at 6.36M$.

Who is the top mutual fund holder of Vor Biopharma shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Vor Biopharma shares, with 3.11% of its total shares outstanding invested in 2.13M Vor Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools